Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults

Clinical trial NCT04493671 · COMPLETED

Trial details

NCT number: NCT04493671
Sponsor: Global Alliance for TB Drug Development
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pulmonary Disease Tuberculosis, Pulmonary Tuberculosis Multi Drug Resistant Tuberculosis Drug Sensitive Tuberculosis Drug-resistant Tuberculosis Mycobacterium Tuberculosis Infection

Start date: 2020-06-08
Primary completion: 2022-06-16
Enrollment: 137

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.